Literature DB >> 30409559

The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment.

Rahul Shinde1, Tracy L McGaha2.   

Abstract

The aryl hydrocarbon receptor (AhR) is a cytoplasmic receptor and transcription factor activated through cognate ligand binding. It is an important factor in immunity and tissue homeostasis, and structurally diverse compounds from the environment, diet, microbiome, and host metabolism can induce AhR activity. Emerging evidence suggests that AhR is a key sensor allowing immune cells to adapt to environmental conditions and changes in AhR activity have been associated with autoimmune disorders and cancer. Furthermore, AhR agonists or antagonists can impact immune disease outcomes identifying AhR as a potentially actionable target for immunotherapy. In this review, we describe known ligands stimulating AhR activity, downstream proinflammatory and suppressive mechanisms potentiated by AhR, and how this understanding is being applied to immunopathology to help control disease outcomes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30409559      PMCID: PMC7182078          DOI: 10.1016/j.it.2018.10.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  126 in total

1.  Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.

Authors:  A McDougal; M Wormke; J Calvin; S Safe
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

3.  Prognostic value of nuclear translocation of aryl hydrocarbon receptor for non-small cell lung cancer.

Authors:  Jang-Ming Su; Pinpin Lin; Han Chang
Journal:  Anticancer Res       Date:  2013-09       Impact factor: 2.480

4.  Consequences of AhR activation in steady-state dendritic cells.

Authors:  Tom Simones; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-11-19       Impact factor: 4.849

5.  Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.

Authors:  Nam Trung Nguyen; Akihiro Kimura; Taisuke Nakahama; Ichino Chinen; Kazuya Masuda; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

6.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

7.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

8.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

Review 9.  Aryl hydrocarbon receptors: diversity and evolution.

Authors:  Mark E Hahn
Journal:  Chem Biol Interact       Date:  2002-09-20       Impact factor: 5.192

10.  In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.

Authors:  Zhong-Ze Fang; Kristopher W Krausz; Kenjiro Nagaoka; Naoki Tanaka; Krishne Gowda; Shantu G Amin; Gary H Perdew; Frank J Gonzalez
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more
  63 in total

Review 1.  The use of fecal microbiota transplant in sepsis.

Authors:  Robert Keskey; Jennifer T Cone; Jennifer R DeFazio; John C Alverdy
Journal:  Transl Res       Date:  2020-07-07       Impact factor: 7.012

Review 2.  Role of AHR in the control of GBM-associated myeloid cells.

Authors:  Galina Gabriely; Francisco J Quintana
Journal:  Semin Cancer Biol       Date:  2019-05-23       Impact factor: 15.707

3.  Vitamin B12 and folic acid alleviate symptoms of nutritional deficiency by antagonizing aryl hydrocarbon receptor.

Authors:  Daniel J Kim; Arvind Venkataraman; Priyanka Caroline Jain; Eleanor P Wiesler; Melody DeBlasio; Jonathan Klein; Stephanie S Tu; Seohyuk Lee; Ruslan Medzhitov; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

4.  Druggability assessment of mammalian Per-Arnt-Sim [PAS] domains using computational approaches.

Authors:  João V de Souza; Sylvia Reznikov; Ruidi Zhu; Agnieszka K Bronowska
Journal:  Medchemcomm       Date:  2019-05-13       Impact factor: 3.597

Review 5.  Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective.

Authors:  Prachi Agnihotri; Sheetal Ramani; Debolina Chakraborty; Mohd Saquib; Sagarika Biswas
Journal:  Curr Rheumatol Rep       Date:  2021-04-28       Impact factor: 4.592

6.  Cellular Stress Upregulates Indole Signaling Metabolites in Escherichia coli.

Authors:  Chung Sub Kim; Jhe-Hao Li; Brenden Barco; Hyun Bong Park; Alexandra Gatsios; Ashiti Damania; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Nicole K Clay; Jason M Crawford
Journal:  Cell Chem Biol       Date:  2020-04-02       Impact factor: 8.116

7.  Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.

Authors:  Heekyong R Bae; Patrick S C Leung; Deborah L Hodge; John M Fenimore; Seon-Min Jeon; Vishal Thovarai; Amiran Dzutsev; Andrew A Welcher; Michael Boedigheimer; Michael A Damore; Myung-Sook Choi; Richard A Fravell; Giorgio Trinchieri; M Eric Gershwin; Howard A Young
Journal:  J Autoimmun       Date:  2020-03-24       Impact factor: 7.094

8.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

9.  The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Authors:  B M Reipert; B Gangadharan; C J Hofbauer; V Berg; H Schweiger; J Bowen; J Blatny; K Fijnvandraat; E S Mullins; J Klintman; C Male; C McGuinn; S L Meeks; V C Radulescu; M V Ragni; M Recht; A D Shapiro; J M Staber; H M Yaish; E Santagostino; D L Brown
Journal:  Blood Adv       Date:  2020-11-24

Review 10.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy.

Authors:  Markus B Geuking; Regula Burkhard
Journal:  Mucosal Immunol       Date:  2020-08-13       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.